In a radio interview with NPR’s Talk of the Nation, CNS faculty member, Jason Karlawish, discusses the implications of a recent study’s findings that the skin cancer drug bexarotene (Targretin) can reduce Alzheimer’s-like symptoms in mice (February 20, 2012: , “Caregivers Press for Experimental Alzheimer’s Drug“)
